Trademark Overview
On Wednesday, November 20, 2024, a trademark application was filed for SOLENO ONE with the United States Patent and Trademark Office. The USPTO has given the SOLENO ONE trademark a serial number of 98863148. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 20, 2024. This trademark is owned by Soleno Therapeutics, Inc.. The SOLENO ONE trademark is filed in the Advertising, Business and Retail Services, Communication Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Communication services, namely, transmission of information relating to pharmaceuticals, medicine, and medical conditions and diseases via all means of telecommunication including the Internet
Administration of patient pharmaceutical reimbursement programs; Administering a patient support and assistance program for obtaining reimbursement for prescription medicines
Providing information in the field of rare diseases and treatment thereof; Providing information in the fields of Prader-Willi syndrome, neurobehavioral diseases, metabolic diseases, endocrine diseases, and diseases characterized by hyperphagia, and the treatment thereof; Pharmaceutical patient support program providing disease awareness and disease management information and materials in the nature of providing a website featuring medical information to improve understanding by patients and caregivers about pharmaceuticals, providing resources to patients in the nature of product information for medical purposes, access to medication, informational materials and information regarding complying with instructions and directions for using medications and medical therapies
Providing a website featuring technology that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing an interactive website that enables users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals; Providing online non-downloadable software for users to access educational and informational materials about medical conditions and diseases, pharmaceutical product and use information, resources for patient support and advocacy programs and treatment affordability programs, and accessing pharmaceuticals
